This article provides a research-focused overview of BPC-157 and TB-500, including their place in peptide literature, formulation discussions, and evidence boundaries for public-facing content
Hypoglycemia, particularly in those using insulin or sulfonylureas, requires close monitoring
Clinical studies shows a reduction of 4% in body weight after 3 months and 9% after 6 months amongst those taking subcutaneous Semaglutide injections for weight loss
Studies show weight loss varies by individual, but many patients lose 1 to 2 pounds per week on semaglutide
Participants taking Mounjaro also saw significant improvements in blood glucose metrics compared to the control group
Piotrowski K, Becker M, Zugwurst J, Biller-Friedmann I, Spoettl G, Greif M, Leber AW, Becker A, Laubender RP, Lebherz C, Goeke B, Marx N, Parhofer KG, Lehrke M: Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans